CD14 and chronic kidney disease: More recently, Borges Bonan and colleagues demonstrated that a combination of uremic toxins, including p-CS and IS, contribute to the increase of intermediate pro-inflammatory monocytes (CD14+ and CD16+) in patients with CKD [73].